Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'

Romano Demicheli, Rosalba Miccli, Cristina Brambilla, Laura Ferrari, Angela Moliterni, Milvia Zambetti, Pinuccia Valagussa, Gianni Bonadonna

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures''. Together they form a unique fingerprint.

Medicine & Life Sciences